Hudson Bay Capital Management
ABEO icon

Hudson Bay Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Hudson Bay Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-19,000
Closed -$1.38M – 535
2020
Q2 		$1.38M Buy
19,000
+10,000
+111% +$691K 0.02% 348
2020
Q1 		$473K Buy
9,000
+6,400
+246% +$427K 0.01% 370
2019
Q4 		$213K Buy
+2,600
New +$183K ﹤0.01% 368
2018
Q2 		– Sell
-2,408
Closed -$864K – 766
2018
Q1 		$864K Buy
+2,408
New +$895K 0.02% 605

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hudson Bay Capital Management's ABEO Position: Q3 2020 in Review

Hudson Bay Capital Management sold out of Abeona Therapeutics (ABEO) in Q3 2020, closing a stake of 19,000 shares — an estimated $1.38M sold.

Hudson Bay Capital Management first reported a position in ABEO in Q1 2018 and held it in 4 quarters. The position peaked at $1.38M in Q2 2020. 78 funds tracked by Wall St. Rank hold ABEO as of Q3 2020.

  • Hudson Bay Capital Management reported no remaining Abeona Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Hudson Bay Capital Management sold 19,000 Abeona Therapeutics shares in Q3 2020, an estimated $1.38M.
  • Hudson Bay Capital Management first reported a position in Abeona Therapeutics in Q1 2018 and held it in 4 quarters.
  • Hudson Bay Capital Management's Abeona Therapeutics position peaked at $1.38M in Q2 2020.
  • 78 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2020.

Based on Hudson Bay Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.